Completed
Phase 2
Age: 26Years - 41Years
MALE
ID00000210
Treatment Efficacy for Drug Abuse and AIDS Prevention
Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
N
National Institute on Drug Abuse (NIDA)
Lead Sponsor
M
Mclean Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.
CONDITIONS
Brief Title
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
Who Can Participate
Age: 26Years - 41Years
MALE
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here